Status:
COMPLETED
Utility of Renal Biomarkers in Cirrhosis
Lead Sponsor:
University Hospital, Geneva
Conditions:
Cirrhosis
Ascitis
Eligibility:
All Genders
18+ years
Brief Summary
Evaluation of kidney function is critical in cirrhotic patients as there is a clear relationship between renal failure and prognosis. The investigators hypothesized that in this population new biomark...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Known or suspected cirrhosis
- Suspected ascitis
- Informed consent signed
Exclusion
- Proven multifocal hepatocellular carcinoma
- Acute gastric hemorrhage (active or \< 2 weeks)
- Known end-stage renal disease or on dialysis before admission
- Recipients of kidney or liver transplants
- Transferred from another institution
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT01217983
Start Date
October 1 2010
End Date
October 1 2012
Last Update
October 30 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Geneva
Geneva, Switzerland, 1211